Yael Cohen
Plus aucun poste en cours
Profil
Yael Cohen worked as a Medical Director at Merck Sharp & Dohme (Israel - 1996) Co. Ltd.
and as a Principal at Merck Research Laboratories Massachusetts LLC.
She also worked as a Vice President & Head-Clinical Development at Gamida Cell Ltd.
and as a Vice President-Clinical Development at Vascular Biogenics Ltd.
Prior to her industry experience, she worked as a Principal at Sheba Medical Center.
Dr. Cohen holds a doctorate degree from Sackler Faculty of Medicine.
Anciens postes connus de Yael Cohen
| Sociétés | Poste | Fin |
|---|---|---|
| Merck Sharp & Dohme (Israel - 1996) Co. Ltd. | Directeur Technique/Scientifique/R&D | - |
| NOTABLE LABS, LTD. | Corporate Officer/Principal | - |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | - |
Sheba Medical Center
 Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Corporate Officer/Principal | - |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Formation de Yael Cohen
| Sackler Faculty of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GAMIDA CELL LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Health Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Merck Sharp & Dohme (Israel - 1996) Co. Ltd. |
